# Safety of Herpes Zoster Subunit (HZ/su) Vaccine During Pregnancy in Adult Women With Immunocompromised Conditions

> **NCT05811754** · — · ACTIVE_NOT_RECRUITING · sponsor: **GlaxoSmithKline** · enrollment: 2844 (estimated)

## Conditions studied

- Herpes Zoster

## Interventions

- **OTHER:** Data collection

## Key facts

- **NCT ID:** NCT05811754
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-05-09
- **Primary completion:** 2028-03-31
- **Final completion:** 2028-03-31
- **Target enrollment:** 2844 (ESTIMATED)
- **Last updated:** 2025-11-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05811754

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05811754, "Safety of Herpes Zoster Subunit (HZ/su) Vaccine During Pregnancy in Adult Women With Immunocompromised Conditions". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT05811754. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*